The company, a direct seller that develops and distributes anti-aging personal care products and nutritional supplements in 53 markets worldwide, said its Chinese operation will "immediately resume corporate-hosted business meetings and will start accepting applications for new sales people" in May.
That comes after a review of its sales and marketing practices.
"China is an important marketplace for Nu Skin and we are committed to operating in full compliance with China's direct selling regulations to promote long-term success," said Dan Chard, president of global sales and operations.
"We plan to continue working cooperatively with regulatory agencies and refine our training procedures to further educate our sales force on local laws and company policies," he added.
TheStreet Ratings team rates NU SKIN ENTERPRISES as a Buy with a ratings score of B. TheStreet Ratings Team has this to say about their recommendation:
"We rate NU SKIN ENTERPRISES (NUS) a BUY. This is driven by a few notable strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, impressive record of earnings per share growth, compelling growth in net income and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow."